These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

262 related items for PubMed ID: 12173297

  • 1. Tumor necrosis factor-alpha blockade: a novel therapy for rheumatic disease.
    Shanahan JC, St Clair W.
    Clin Immunol; 2002 Jun; 103(3 Pt 1):231-42. PubMed ID: 12173297
    [Abstract] [Full Text] [Related]

  • 2. [Are there any positive effects of TNF-alpha blockers on bone metabolism?].
    Seriolo B, Paolino S, Sulli A, Cutolo M.
    Reumatismo; 2006 Jun; 58(3):199-205. PubMed ID: 17013436
    [Abstract] [Full Text] [Related]

  • 3. TNF blockade in the treatment of rheumatoid arthritis: infliximab versus etanercept.
    Mikuls TR, Moreland LW.
    Expert Opin Pharmacother; 2001 Jan; 2(1):75-84. PubMed ID: 11336570
    [Abstract] [Full Text] [Related]

  • 4. Tumour necrosis factor-alpha blockade: a new era for effective management of rheumatoid arthritis.
    Hamilton K, Clair EW.
    Expert Opin Pharmacother; 2000 Jul; 1(5):1041-52. PubMed ID: 11249494
    [Abstract] [Full Text] [Related]

  • 5. [How I treat...rheumatoid arthritis. The arrival of a new therapeutic era: anti-tumor necrosis factor alpha antibodies].
    Kaiser MJ, Malaise MG.
    Rev Med Liege; 2002 Aug; 57(8):486-92. PubMed ID: 12405019
    [Abstract] [Full Text] [Related]

  • 6. Medication effectiveness with the use of tumor necrosis factor inhibitors among Texas Medicaid patients diagnosed with rheumatoid arthritis.
    Oladapo A, Barner JC, Lawson KA, Novak S, Rascati KL, Richards KM, Harrison DJ.
    J Manag Care Spec Pharm; 2014 Jul; 20(7):657-67. PubMed ID: 24967519
    [Abstract] [Full Text] [Related]

  • 7. [Copernican revolution in the therapy of rheumatoid arthritis: the contribution of anti-TNFalpha drugs].
    Bombardieri S, Ferraccioli G, Ferri C, Galeazzi M, Lapadula G, Cerinic MM, Montecucco C, Triolo G, Trotta F, Valentini G.
    Reumatismo; 2009 Jul; 61 Suppl 1():1-23. PubMed ID: 19999184
    [Abstract] [Full Text] [Related]

  • 8. [New drugs and treatment strategies for rheumatoid arthritis].
    Fantini F.
    Recenti Prog Med; 2003 Sep; 94(9):361-79. PubMed ID: 12942798
    [Abstract] [Full Text] [Related]

  • 9. Anti-TNF agents for rheumatoid arthritis.
    Seymour HE, Worsley A, Smith JM, Thomas SH.
    Br J Clin Pharmacol; 2001 Mar; 51(3):201-8. PubMed ID: 11298065
    [Abstract] [Full Text] [Related]

  • 10. The soluble tumor necrosis factor receptor etanercept: a new strategy for the treatment of autoimmune rheumatic disease.
    Cole P, Rabasseda X.
    Drugs Today (Barc); 2004 Apr; 40(4):281-324. PubMed ID: 15190385
    [Abstract] [Full Text] [Related]

  • 11. Anti-tumor necrosis factor therapy increases synovial osteoprotegerin expression in rheumatoid arthritis.
    Catrina AI, af Klint E, Ernestam S, Catrina SB, Makrygiannakis D, Botusan IR, Klareskog L, Ulfgren AK.
    Arthritis Rheum; 2006 Jan; 54(1):76-81. PubMed ID: 16385498
    [Abstract] [Full Text] [Related]

  • 12. [TNF inhibitors for treatment of rheumatoid arthritis].
    Otomo K, Koike T.
    Nihon Naika Gakkai Zasshi; 2008 Oct 10; 97(10):2405-12. PubMed ID: 19149036
    [No Abstract] [Full Text] [Related]

  • 13. [Should we be afraid of the anti-TNFalpha drugs in 2008?].
    Gaudin P.
    Rev Med Interne; 2008 Dec 10; 29(12):971-4. PubMed ID: 18571291
    [No Abstract] [Full Text] [Related]

  • 14. Lipid profile of rheumatoid arthritis patients treated with anti-tumor necrosis factor-alpha drugs changes according to disease activity and predicts clinical response.
    Cacciapaglia F, Anelli MG, Rinaldi A, Serafino L, Covelli M, Scioscia C, Iannone F, Lapadula G.
    Drug Dev Res; 2014 Nov 10; 75 Suppl 1():S77-80. PubMed ID: 25381986
    [Abstract] [Full Text] [Related]

  • 15. Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned?
    Feldmann M, Maini RN.
    Annu Rev Immunol; 2001 Nov 10; 19():163-96. PubMed ID: 11244034
    [Abstract] [Full Text] [Related]

  • 16. Emerging role of anti-tumor necrosis factor therapy in rheumatic diseases.
    Kalden JR.
    Arthritis Res; 2002 Nov 10; 4 Suppl 2(Suppl 2):S34-40. PubMed ID: 12110156
    [Abstract] [Full Text] [Related]

  • 17. [Biologic therapy with anti-TNFα in rheumathoid arthritis].
    Ferraccioli G.
    Reumatismo; 2005 Nov 10; 57(4 Suppl):17-21. PubMed ID: 16385351
    [Abstract] [Full Text] [Related]

  • 18. Down-titration and discontinuation strategies of tumor necrosis factor-blocking agents for rheumatoid arthritis in patients with low disease activity.
    van Herwaarden N, den Broeder AA, Jacobs W, van der Maas A, Bijlsma JW, van Vollenhoven RF, van den Bemt BJ.
    Cochrane Database Syst Rev; 2014 Sep 29; (9):CD010455. PubMed ID: 25264908
    [Abstract] [Full Text] [Related]

  • 19. Anti-tumor necrosis factor therapies.
    Taylor PC.
    Curr Opin Rheumatol; 2001 May 29; 13(3):164-9. PubMed ID: 11333343
    [Abstract] [Full Text] [Related]

  • 20. Treatment of rheumatoid arthritis by TNF-blocking agents.
    Graninger W, Smolen J.
    Int Arch Allergy Immunol; 2002 Jan 29; 127(1):10-4. PubMed ID: 11893849
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.